NAD Recommends All Health Systems Discontinue All Challenged Claims for Company’s ‘Big C’ Supplement, Including Implied Cancer-Prevention Claims

New York, NY – May 11, 2015 – The National Advertising Division has recommended that All Health Systems, LLC, discontinue challenged advertising claims for the company’s “Big C” dietary supplements, including any claims that state or suggest the supplement can be used to prevent, treat or manage cancer.  The advertiser has agreed to do so.

NAD is an investigative unit of the advertising industry system of self-regulation. It is administered by the Council of Better Business Bureaus.

The claims at issue in this review were challenged by the Council for Responsible Nutrition and include:

  • “This is the most advanced product to help keep you your body stay in favorable conditions so that it may not get this terrible disease.”
  • “Research the 16 ingredients, they all have shown different positive results in battling cancer in various lab studies and may help. In combination, this is ground breaking.”
  • “As many as 70% of known causes of cancers are avoidable and are related to diet and lifestyle.”

NAD also considered whether the advertising claims implied that Big “C” can be used to prevent, treat or manage cancer.

The advertiser represented to NAD that the challenged claims would be permanently discontinued: “In the spirit of self-regulation, All Health Systems, LLC, agrees to take NAD’s recommendations into account in future advertising. The site has been offline for a malicious server issue, as soon as we can get into the site, the wording will be deleted.”

NAD noted in its decision that it appreciated the advertiser’s voluntarily undertaking to permanently discontinue the challenged claims.  Given the lack of evidence in the record, NAD found such action to be necessary and appropriate.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Refers “Made in USA” Claims by Larose Industries d/b/a Roseart and Cra-Z-Art to the Federal Trade Commission

New York, NY – January 10, 2025 – The National Advertising Division referred advertising claims by Larose Industries, operating under the names Roseart and Cra-Z-Art, that its products are “Made in USA” to the Federal Trade Commission (FTC) after Larose Industries failed to respond to the inquiry.

Read the Decision Summary
Decision

National Advertising Division Recommends T-Mobile Discontinue or Modify 20% Savings vs. ‘The Other Big Guys’ Claim; T-Mobile to Appeal

New York, NY – January 9, 2025 – The National Advertising Division recommended that T-Mobile discontinue or modify its advertising to avoid conveying the comparative claim that consumers can “save 20% every month vs. the other big guys” if they subscribe to T-Mobile in markets where Spectrum Mobile also...

Read the Decision Summary
Decision

In National Advertising Division Fast-Track SWIFT Challenge Behr Voluntarily Discontinues “No Comparable Product” Claim

New York, NY – January 8, 2025 – In a National Advertising Division Fast-Track SWIFT challenge brought by Benjamin Moore, Behr voluntarily discontinued its “No Comparable Product” claim.

Read the Decision Summary
Decision

National Advertising Division Finds Charter’s “Unlimited” Claims Supported; Recommends Clear & Conspicuous Speed Limitation Disclosures

New York, NY – January 7, 2025 – The National Advertising Division found that Charter substantiated certain express and implied claims about its Spectrum Mobile “Unlimited” and “Unlimited Plus” wireless data plans but recommended that Charter modify its website advertising to disclose high speed data...

Read the Decision Summary